Clinical Trials in Ohio

Showing 5401-5420 of 15,929 trials

COMPLETEDNA26 miles

Performance Evaluation of Different Daily Disposable Silicone Hydrogel Contact Lenses

NCT05805059

The goal of this study is to compare the performance of two daily disposable silicone hydrogel contact lenses.

Myopia

CooperVision, Inc.68 participantsStarted Apr 2023

Ocoee, Florida, United States • Vestal, New York, United States • Granville, Ohio, United States +1 more locations

TERMINATEDPhase 332 miles

Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment

NCT02548351

The primary objectives of this study are to evaluate the effect of Obeticholic Acid treatment compared to placebo on 1) histological improvement and 2) liver-related clinical outcomes in patients with non-cirrhotic nonalcoholic steatohepatitis (NASH) with liver fibrosis.

Non Alcoholic Steatohepatitis (NASH)

Intercept Pharmaceuticals2,477 participantsStarted Sep 2015

Birmingham, Alabama, United States • Dothan, Alabama, United States • Chandler, Arizona, United States +343 more locations

Performance Evaluation of Different Daily Disposable Silicone Hydrogel Contact Lenses

Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment

Find Trials by Condition in Ohio

Inspiring New Science In Guiding Healthcare in Turner Syndrome Registry

Safety and Tolerability of GTX-104 Compared with Oral Nimodipine in Patients with ASAH

Ravulizumab in Thrombotic Microangiopathy Associated With a Trigger

Pharmacokinetic Drug-drug Interaction Study of Encorafenib and Binimetinib on Probe Drugs in Patients With BRAF V600-mutant Melanoma or Other Advanced Solid Tumors

Post-Market Study to Assess Outcomes of Patients Treated With AFX System Compared to Other EVAR Devices

Open-Label Extension Study of Trofinetide for Rett Syndrome

A Bioequivalence Study Between the Proposed and Current Talazoparib Capsule Formulation and Food Effect Study for the Proposed Talazoparib Capsule Formulation in Participants With Advanced Solid Tumors

Compare Two Copper IUDs: Mona Lisa NT Cu380 Mini and ParaGard

QUILT-2.017: Phase 1b/2 Study of AMG 479 in Combination With Paclitaxel and Carboplatin for 1st Line Treatment of Advanced Squamous Non-Small Cell Lung Cancer

Promote Weight Loss in Obese Peripheral Artery Disease (PAD) Patients to Prevent Mobility Loss

Dose De-escalation Study of the PI3k Alpha/Delta Inhibitor, Copanlisib Given in Combination With the Immunotherapeutic Agents, Nivolumab and Rituximab in Patients With Relapsed/Refractory Indolent Lymphoma

A Study to Investigate the Efficacy and Safety of RG7774 in Patients With Diabetes Mellitus Type 1 or Type 2 With Treatment-Naive Diabetic Retinopathy

Intravascular Ultrasound-Guided Intervention for Venous Leg Ulcers (IGuideU)

A Study of Anti-PD-L1 Checkpoint Antibody (LY3300054) Alone and in Combination in Participants With Advanced Refractory Solid Tumors

Treatment Efforts Addressing Child Weight Management by Unifying Patients, Parents & Providers

Study Comparing Trifarotene Cream, 0.005% To AKLIEF ® (Trifarotene 0.005% Cream) In The Treatment Of Acne Vulgaris

BD OneFlow CLPD Panel (BD OneFlow LST, and B-CLPD T1 to T4 Assays) on the BD FACSLyric System.

MK-8189 Safety and Tolerability in Participants With Alzheimer's Disease With or Without Symptoms of Agitation-Aggression and/or Psychosis (MK-8189-017)